Published in Obstet Gynecol on June 01, 2011
Deus ex Makena? Obstet Gynecol (2011) 1.39
Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection. Drug Dev Ind Pharm (2012) 1.38
Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitals. Am J Obstet Gynecol (2015) 1.00
17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study. Am J Obstet Gynecol (2017) 0.76
Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol (2006) 5.99
Point-of-care ultrasonography. N Engl J Med (2011) 5.42
Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop. Obstet Gynecol (2012) 4.63
A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med (2003) 4.04
The impact of the active management of risk in pregnancy at term on birth outcomes: a randomized clinical trial. Am J Obstet Gynecol (2008) 3.16
Effectiveness of electronic fetal monitoring with additional ST analysis in vertex singleton pregnancies at >36 weeks of gestation: an individual participant data metaanalysis. Am J Obstet Gynecol (2013) 3.10
A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis. N Engl J Med (2015) 2.86
Combination of Foley bulb and vaginal misoprostol compared with vaginal misoprostol alone for cervical ripening and labor induction: a randomized controlled trial. Obstet Gynecol (2013) 2.67
Impact of maternal age on obstetric outcome. Obstet Gynecol (2005) 2.60
Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation (2008) 2.54
First-trimester septated cystic hygroma: prevalence, natural history, and pediatric outcome. Obstet Gynecol (2005) 2.40
The National Partnership for Maternal Safety. Obstet Gynecol (2014) 2.39
Maternal mortality: time for national action. Obstet Gynecol (2013) 2.32
First- and second-trimester evaluation of risk for Down syndrome. Obstet Gynecol (2007) 2.31
Progress of labor in women induced with misoprostol versus the Foley catheter. Am J Obstet Gynecol (2013) 2.22
First trimester ultrasound screening is effective in reducing postterm labor induction rates: a randomized controlled trial. Am J Obstet Gynecol (2004) 2.22
Interval from loop electrosurgical excision procedure to pregnancy and pregnancy outcomes. Obstet Gynecol (2013) 2.15
Quality patient care in labor and delivery: a call to action. Am J Obstet Gynecol (2012) 2.12
Defining nasal bone hypoplasia in second-trimester Down syndrome screening: does the use of multiples of the median improve screening efficacy? Am J Obstet Gynecol (2007) 2.12
Active management of risk in pregnancy at term in an urban population: an association between a higher induction of labor rate and a lower cesarean delivery rate. Am J Obstet Gynecol (2004) 2.08
Radiographic measures of the mid pelvis to predict cesarean delivery. Am J Obstet Gynecol (2013) 2.08
Terminal fetal heart decelerations and neonatal outcomes. Obstet Gynecol (2013) 2.05
Antiphospholipid antibodies in stillbirth. Obstet Gynecol (2013) 2.04
Limited obstetric ultrasound examinations: competency and cost. J Obstet Gynecol Neonatal Nurs (2003) 2.03
Loop electrosurgical excision procedure and risk of preterm birth: a systematic review and meta-analysis. Obstet Gynecol (2014) 2.00
AlgK is a TPR-containing protein and the periplasmic component of a novel exopolysaccharide secretin. Structure (2010) 1.97
Staples compared with subcuticular suture for skin closure after cesarean delivery: a systematic review and meta-analysis. Obstet Gynecol (2011) 1.81
Vaginal birth after caesarean section versus elective repeat caesarean section: assessment of maternal downstream health outcomes. BJOG (2006) 1.81
Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol (2010) 1.77
Single umbilical artery and its associated findings. Obstet Gynecol (2010) 1.76
Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med (2007) 1.75
The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am J Obstet Gynecol (2007) 1.65
Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation (2014) 1.64
Congenital uterine anomalies and adverse pregnancy outcomes. Am J Obstet Gynecol (2011) 1.60
Is fetal gender associated with adverse perinatal outcome in intrauterine growth restriction (IUGR)? Am J Obstet Gynecol (2005) 1.56
Karyotype versus microarray testing for genetic abnormalities after stillbirth. N Engl J Med (2012) 1.56
Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol (2009) 1.54
Hospital readmission after delivery: evidence for an increased incidence of nonurogenital infection in the immediate postpartum period. Am J Obstet Gynecol (2009) 1.54
The association between increased use of labor induction and reduced rate of cesarean delivery. J Womens Health (Larchmt) (2009) 1.53
Risk factors for sleep-disordered breathing in pregnancy. Thorax (2013) 1.52
Fetal adrenal gland volume: a novel method to identify women at risk for impending preterm birth. Obstet Gynecol (2007) 1.50
Association of atypical decelerations with acidemia. Obstet Gynecol (2012) 1.50
Higher maximum doses of oxytocin are associated with an unacceptably high risk for uterine rupture in patients attempting vaginal birth after cesarean delivery. Am J Obstet Gynecol (2008) 1.50
Risk of stillbirth after 37 weeks in pregnancies complicated by small-for-gestational-age fetuses. Am J Obstet Gynecol (2013) 1.49
17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. Am J Obstet Gynecol (2012) 1.49
Emerging concepts in antibiotic prophylaxis for cesarean delivery: a systematic review. Obstet Gynecol (2009) 1.48
A randomized trial of amnioreduction versus septostomy in the treatment of twin-twin transfusion syndrome. Am J Obstet Gynecol (2005) 1.48
A population-based case-control study of stillbirth: the relationship of significant life events to the racial disparity for African Americans. Am J Epidemiol (2013) 1.48
Sleep deprivation during pregnancy and maternal and fetal outcomes: is there a relationship? Sleep Med Rev (2009) 1.47
Evaluating the rate and risk factors for fetal loss after chorionic villus sampling. Obstet Gynecol (2008) 1.46
Predicting adverse neonatal outcomes in fetuses with abdominal wall defects using prenatal risk factors. Am J Obstet Gynecol (2009) 1.46
The fetal origins of hypertension: a systematic review and meta-analysis of the evidence from animal experiments of maternal undernutrition. J Hypertens (2012) 1.46
Safety and efficacy of vaginal birth after cesarean attempts at or beyond 40 weeks of gestation. Obstet Gynecol (2005) 1.45
Contingent screening for Down syndrome--results from the FaSTER trial. Prenat Diagn (2008) 1.45
Utility of the bladder flap at cesarean delivery: a randomized controlled trial. Obstet Gynecol (2012) 1.44
Impact of a comprehensive patient safety strategy on obstetric adverse events. Am J Obstet Gynecol (2009) 1.43
Comparison of serum markers in first-trimester down syndrome screening. Obstet Gynecol (2006) 1.43
Diagnosis of cardiac defects: where we've been, where we are and where we're going. Prenat Diagn (2002) 1.43
Impact of fetal gender on the labor curve. Am J Obstet Gynecol (2012) 1.42
Effect of gestational age and position on peak expiratory flow rate: a longitudinal study. Obstet Gynecol (2005) 1.42
Timing of perioperative antibiotics for cesarean delivery: a metaanalysis. Am J Obstet Gynecol (2008) 1.41
Choroid plexus cyst and echogenic intracardiac focus in women at low risk for chromosomal anomalies: the obligation to inform the mother. J Ultrasound Med (2004) 1.39
Comparison of the efficiency of second-trimester nasal bone hypoplasia and increased nuchal fold in Down syndrome screening. Am J Obstet Gynecol (2008) 1.39
A suggested approach for implementing CONSORT guidelines specific to obstetric research. Obstet Gynecol (2013) 1.38
Identification of intracellular bacteria in the basal plate of the human placenta in term and preterm gestations. Am J Obstet Gynecol (2013) 1.33
Stillbirth Collaborative Research Network: design, methods and recruitment experience. Paediatr Perinat Epidemiol (2011) 1.31
Predicting failure of a vaginal birth attempt after cesarean delivery. Obstet Gynecol (2007) 1.30
Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia. Obstet Gynecol (2010) 1.26
The Preterm Prediction Study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth. Am J Obstet Gynecol (2002) 1.22
Short interpregnancy interval: risk of uterine rupture and complications of vaginal birth after cesarean delivery. Obstet Gynecol (2007) 1.21
Excessive early gestational weight gain and risk of gestational diabetes mellitus in nulliparous women. Obstet Gynecol (2012) 1.20
Is vaginal birth after cesarean (VBAC) or elective repeat cesarean safer in women with a prior vaginal delivery? Am J Obstet Gynecol (2006) 1.19
Associations between free fatty acids, cumulus oocyte complex morphology and ovarian function during in vitro fertilization. Fertil Steril (2011) 1.18
A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod (2002) 1.17
A comprehensive obstetrics patient safety program improves safety climate and culture. Am J Obstet Gynecol (2011) 1.17
False-positive 1-hour glucose challenge test and adverse perinatal outcomes. Obstet Gynecol (2004) 1.17
Putting the "M" back in maternal-fetal medicine. Am J Obstet Gynecol (2012) 1.14
Periodontal disease and adverse pregnancy outcomes: is there an association? Am J Obstet Gynecol (2009) 1.14
Maternal-fetal medicine specialist density is inversely associated with maternal mortality ratios. Am J Obstet Gynecol (2005) 1.12
Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center's 16-year experience. Obstet Gynecol (2008) 1.12
Late preterm birth: how often is it avoidable? Am J Obstet Gynecol (2009) 1.11
Comparing uterine electromyography activity of antepartum patients versus term labor patients. Am J Obstet Gynecol (2005) 1.10
Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. Am J Cardiol (2009) 1.10
Uptake of influenza vaccine in pregnant women during the 2009 H1N1 influenza pandemic. Am J Obstet Gynecol (2011) 1.09
Association and prediction of neonatal acidemia. Am J Obstet Gynecol (2012) 1.08
Evaluating the incidence and likelihood ratios for chromosomal abnormalities in fetuses with common central nervous system malformations. Am J Obstet Gynecol (2008) 1.08
Underwater births. Pediatrics (2005) 1.07
Maternal mortality, near misses, and severe morbidity: lowering rates through designated levels of maternity care. Obstet Gynecol (2012) 1.07
Labor-associated gene expression in the human uterine fundus, lower segment, and cervix. PLoS Med (2006) 1.06
A new system for determining the causes of stillbirth. Obstet Gynecol (2010) 1.06
Characterization of abdominally acquired uterine electrical signals in humans, using a non-linear analytic method. Med Biol Eng Comput (2006) 1.06
Clinical outcomes in VBAC attempts: what to say to patients? Am J Obstet Gynecol (2008) 1.05
Leiomyomas at routine second-trimester ultrasound examination and adverse obstetric outcomes. Obstet Gynecol (2010) 1.05
The association between prepregnancy maternal body mass index and preterm delivery. Am J Perinatol (2009) 1.05